Westfield Capital Management
CORV

Westfield Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Westfield Capital Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,876,455
Closed -$9.75M – 265
2019
Q3 		$9.75M Buy
4,876,455
+51,200
+1% +$104K 0.08% 185
2019
Q2 		$10.4M Buy
4,825,255
+37,223
+0.8% +$95.1K 0.08% 194
2019
Q1 		$15.1M Buy
4,788,032
+50,228
+1% +$162K 0.12% 189
2018
Q4 		$11.8M Sell
4,737,804
-36,345
-0.8% -$121K 0.1% 184
2018
Q3 		$19.2M Buy
4,774,149
+146,195
+3% +$645K 0.13% 184
2018
Q2 		$17.5M Buy
4,627,954
+435,920
+10% +$1.14M 0.13% 190
2018
Q1 		$9.73M Sell
4,192,034
-486,330
-10% -$769K 0.08% 201
2017
Q4 		$7.25M Sell
4,678,364
-180,090
-4% -$289K 0.06% 204
2017
Q3 		$10.3M Sell
4,858,454
-427,886
-8% -$1.46M 0.08% 203
2017
Q2 		$23.9M Buy
5,286,340
+391,392
+8% +$1.42M 0.2% 157
2017
Q1 		$14.7M Sell
4,894,948
-183,445
-4% -$541K 0.13% 194
2016
Q4 		$14M Sell
5,078,393
-318,614
-6% -$911K 0.12% 201
2016
Q3 		$16.9M Buy
5,397,007
+1,487,915
+38% +$5.42M 0.14% 184
2016
Q2 		$20M Sell
3,909,092
-59,153
-1% -$284K 0.17% 159
2016
Q1 		$16.2M Buy
3,968,245
+126,415
+3% +$676K 0.12% 178
2015
Q4 		$31.2M Buy
3,841,830
+619,435
+19% +$5.16M 0.21% 140
2015
Q3 		$27.2M Buy
3,222,395
+468,885
+17% +$4.32M 0.19% 146
2015
Q2 		$25.9M Buy
2,753,510
+516,933
+23% +$4.82M 0.16% 167
2015
Q1 		$20.7M Buy
2,236,577
+715,390
+47% +$6.85M 0.12% 205
2014
Q4 		$14.1M Buy
1,521,187
+790,261
+108% +$6.65M 0.08% 223
2014
Q3 		$6.53M Buy
730,926
+453,762
+164% +$3.3M 0.04% 231
2014
Q2 		$2.18M Sell
277,164
-22,900
-8% -$173K 0.01% 248
2014
Q1 		$2.37M Buy
+300,064
New +$2.41M 0.01% 254

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Westfield Capital Management's CORV Position: Q4 2019 in Review

Westfield Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 4,876,455 shares — an estimated $9.75M sold.

Westfield Capital Management first reported a position in CORV in Q1 2014 and held it in 23 quarters. The position peaked at $31.2M in Q4 2015. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Westfield Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Westfield Capital Management sold 4,876,455 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $9.75M.
  • Westfield Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 23 quarters.
  • Westfield Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $31.2M in Q4 2015.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.